Anti-DLL4 Antibody is a highly specialized monoclonal antibody target the delta-like ligand 4 within the Notch signaling axis, disruption of ligand-receptor engagement to modulate both vascular organization and tumor cell differentiation across various preclinical experimental oncology models.
Target:
Gamma-secretase
T9901A-1407
* VAT and and shipping costs not included. Errors and price changes excepted
